The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS IN | COM | 004225108 | 3,739,599 | 179,702 | SH | SOLE | 179,702 | 0 | 0 | |||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 593,520 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | |||
AKERO THERAPEUTICS INC CO | COM | 00973Y108 | 935,174 | 18,489 | SH | SOLE | 18,489 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS I | COM | 02043Q107 | 6,517,280 | 36,800 | SH | SOLE | 36,800 | 0 | 0 | |||
AMGEN INC COM | COM | 031162100 | 21,297,363 | 79,246 | SH | SOLE | 79,246 | 0 | 0 | |||
AMICUS THERAPEUTICS INC C | COM | 03152W109 | 1,092,600 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
AMYLYX PHARMS. | COM | 03237H101 | 5,398,500 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | |||
ARVINAS INC COM | COM | 04335A105 | 333,540 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | |||
ASTRAZENECA PLC SPONSORED | SPONSORED ADR | 046353108 | 3,148,515 | 46,500 | SH | SOLE | 46,500 | 0 | 0 | |||
AURINIA PHARMACEUTICALS I | COM | 05156V102 | 8,074,513 | 1,040,530 | SH | SOLE | 1,040,530 | 0 | 0 | |||
AXSOME THERAPEUTICS INC. | COM | 05464T104 | 4,071,089 | 58,300 | SH | SOLE | 58,300 | 0 | 0 | |||
BEAM THERAPEUTICS INC COM | COM | 07373V105 | 564,705 | 23,500 | SH | SOLE | 23,500 | 0 | 0 | |||
BEIGENE LTD SPONSORED ADR | Sponsored ADR | 07725L102 | 2,281,555 | 12,700 | SH | SOLE | 12,700 | 0 | 0 | |||
BIOGEN INC COMMON STOCK | COM | 09062X103 | 10,333,812 | 40,200 | SH | SOLE | 40,200 | 0 | 0 | |||
BIOMARIN PHARMACEUTICAL I | COM | 09061G101 | 13,595,483 | 153,656 | SH | SOLE | 153,656 | 0 | 0 | |||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 1,002,200 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 1,322,242 | 48,099 | SH | SOLE | 48,099 | 0 | 0 | |||
COGENT BIOSCIENCES | COM | 19240Q201 | 1,313,550 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | |||
CRISPR THERAPEUTICS AG CO | NAMEN AKT | H17182108 | 2,858,940 | 63,000 | SH | SOLE | 63,000 | 0 | 0 | |||
CYTOKINETICS INC COMMON S | COM NEW | 23282W605 | 1,090,020 | 37,000 | SH | SOLE | 37,000 | 0 | 0 | |||
DENALI THERAPEUTICS INC C | COM | 24823R105 | 3,172,400 | 154,000 | SH | SOLE | 154,000 | 0 | 0 | |||
DYNE THERAPEUTICS INC COM | COM | 26818M108 | 1,231,494 | 137,751 | SH | SOLE | 137,751 | 0 | 0 | |||
ERASCA INC COM | COM | 29479A108 | 3,794,220 | 1,926,000 | SH | SOLE | 1,926,000 | 0 | 0 | |||
GENMAB -SP ADR | SPONSORED ADS | 372303206 | 1,561,575 | 44,300 | SH | SOLE | 44,300 | 0 | 0 | |||
GILEAD SCIENCES INC COMMO | COM | 375558103 | 17,507,121 | 233,584 | SH | SOLE | 233,584 | 0 | 0 | |||
GUARDANT HEALTH INC COM | COM | 40131M109 | 1,081,130 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | |||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 2,376,040 | 62,200 | SH | SOLE | 62,200 | 0 | 0 | |||
Harmony Biosciences Holdi | COM | 413197104 | 10,306,165 | 314,500 | SH | SOLE | 314,500 | 0 | 0 | |||
ILLUMINA INC COM | COM | 452327109 | 6,932,640 | 50,500 | SH | SOLE | 50,500 | 0 | 0 | |||
I-MAB SPONSORED ADS | SPONSORED ADS | 44975P103 | 409,859 | 310,499 | SH | SOLE | 310,499 | 0 | 0 | |||
INCYTE CORP INC COM | COM | 45337C102 | 20,704,303 | 358,454 | SH | SOLE | 358,454 | 0 | 0 | |||
INSMED INC COM PAR $.01 | COM | 457669307 | 1,012,124 | 40,100 | SH | SOLE | 40,100 | 0 | 0 | |||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 757,920 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | |||
INTRA-CELLULAR THERAPIES | COM | 46116X101 | 16,547,583 | 317,856 | SH | SOLE | 317,856 | 0 | 0 | |||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 1,949,190 | 43,000 | SH | SOLE | 43,000 | 0 | 0 | |||
IOVANCE BIOTHERAPEUTICS I | COM | 462260100 | 2,024,750 | 445,000 | SH | SOLE | 445,000 | 0 | 0 | |||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 2,225,164 | 17,200 | SH | SOLE | 17,200 | 0 | 0 | |||
KARUNA THERAPEUTICS INC C | COM | 48576A100 | 5,157,245 | 30,500 | SH | SOLE | 30,500 | 0 | 0 | |||
KEZAR LIFE SCIENCES | COM | 49372L100 | 830,514 | 703,825 | SH | SOLE | 703,825 | 0 | 0 | |||
KRYSTAL BIOTECH INC COM | COM | 501147102 | 5,344,828 | 46,092 | SH | SOLE | 46,092 | 0 | 0 | |||
Legend Biotech Corp | SPONSORED ADS | 52490G102 | 2,551,320 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS | COM | 558868105 | 2,669,421 | 18,300 | SH | SOLE | 18,300 | 0 | 0 | |||
MARINUS PHARMACEUTICALS I | COM NEW | 56854Q200 | 2,337,400 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | |||
MIRATI THERAPEUTICS INC C | COM | 60468T105 | 9,404,640 | 216,000 | SH | SOLE | 216,000 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 2,128,950 | 67,500 | SH | SOLE | 67,500 | 0 | 0 | |||
NEUROCRINE BIOSCIENCES IN | COM | 64125C109 | 3,247,219 | 28,877 | SH | SOLE | 28,877 | 0 | 0 | |||
Novocure Ltd | ORD SHS | G6674U108 | 1,193,620 | 74,000 | SH | SOLE | 74,000 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS | COM | 74366E102 | 331,932 | 19,900 | SH | SOLE | 19,900 | 0 | 0 | |||
PROTHENA CORP PLC USD0.01 | COM | G72800108 | 722,850 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
PTC THERAPEUTICS INC COM | COM | 69366J200 | 380,630 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | |||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 7,278,338 | 8,847 | SH | SOLE | 8,847 | 0 | 0 | |||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 30,000 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 3,308,800 | 288,726 | SH | SOLE | 288,726 | 0 | 0 | |||
ROCKET PHARMACEUTICALS IN | COM | 77313F106 | 3,193,320 | 156,000 | SH | SOLE | 156,000 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 3,234,972 | 26,700 | SH | SOLE | 26,700 | 0 | 0 | |||
SUPERNUS PHARMACEUTICALS | COM | 868459108 | 11,754,340 | 426,500 | SH | SOLE | 426,500 | 0 | 0 | |||
ULTRAGENYX PHARMACEUTICAL | COM | 90400D108 | 8,914,354 | 250,052 | SH | SOLE | 250,052 | 0 | 0 | |||
UNIQURE N.V. COM EUR0.05 | SHS | N90064101 | 8,330,465 | 1,241,500 | SH | SOLE | 1,241,500 | 0 | 0 | |||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 7,657,755 | 33,959 | SH | SOLE | 33,959 | 0 | 0 | |||
VENTYX BIOSCIENCES INC CO | COM | 92332V107 | 520,650 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
VERA THERAPEUTICS | CL A | 92337R101 | 10,381,880 | 758,355 | SH | SOLE | 758,355 | 0 | 0 | |||
VERTEX PHARMACEUTICALS IN | COM | 92532F100 | 7,302,540 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | |||
VIR BIOTECHNOLOGY INC COM | COM | 92764N102 | 439,920 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,121,980 | 91,500 | SH | SOLE | 91,500 | 0 | 0 | |||
ZAI LAB LTD ADR | ADR | 98887Q104 | 1,917,890 | 78,958 | SH | SOLE | 78,958 | 0 | 0 |